marijuana stocks news

Form 8-K for CARA THERAPEUTICS, INC.


11-Jan-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01. Regulation FD Disclosure.A copy of the investor presentation that Cara Therapeutics, Inc. plans to use in conjunction with meetings, beginning on January 11, 2016, during the J.P. Morgan Healthcare Conference is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information contained in the presentation furnished as Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and is not incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing.

 

Item 9.01. Financial Statements and Exhibits.(d) Exhibits

Exhibit
No. Description

99.1 Cara Therapeutics, Inc. Corporate Presentation January, 2016.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Trulieve Cannabis Corp. (TCNNF) Acquires 64,000 sq. ft. Cultivation Facility in Phoenix

Trulieve Acquires 64,000 sq. ft. Cultivation Facility in Phoenix Trulieve Cannabis Corp.…

 Aurora Cannabis Inc. (ACB) Announces Financial Results for the Fourth Quarter and 2019 Fiscal Year

Aurora Cannabis Announces Financial Results for the Fourth Quarter and 2019 Fiscal…

$LXRP Announces New President for Subsidiary ViPova(TM)

ViPova(TM) by Lexaria Announces New President KELOWNA, BC / ACCESSWIRE / December…

 Neptune Wellness Solutions Inc. (NEPT) Successfully Completes Submission to U.S. FDA

Neptune Successfully Completes Submission to U.S. FDA for Registration of its Conover,…